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KAJIAN ANTIHYPERTENSIF IN VIVO DAN KAJIAN VASODILATORI IN 
VITRO BAGI BANXIA BAIZHU TIANMA TANG YANG TERUBAHSUAI: 
PENGOPTIMUMAN FARMAKOLOGI MENGGUNAKAN MODEL 
KESERASIAN TINDAKBALAS RANGSANGAN ORTOGONAL  
 
ABSTRAK 
Banxia Tianma Baizhu Tang (BBT) adalah antara ubat Tradisional Cina 
(TCM) yang paling kerap digunakan untuk merawat hipertensi. Namun demikian, 
perbezaan lokasi, masa penuaian dan pemprosesan berbanding dengan zaman dahulu 
menyebabkan pengubaisuaian formula ini amat diperlukan. Walaupun pengubahsuaian 
BBT pernah dikaji (hanya dengan penambahan satu atau dua herba dalam BBT), 
pengubahsuaian BBT yang dioptimumkan untuk anti-hipertensi belum pernah lagi 
dilakukan. Kesahihan enam herba mentah BBT telah disahkan dengan menggunakan 
kaedah pengenalan cap jari kromatografi lapisan tipis pretasi tinggi (HPTLC) dan fourier 
transform inframerah (FTIR) sebelum eksperimen dijalankan. Tiga pelarut (95%, 50% 
etanol dan air) telah digunakan untuk proses pengolahan. Kesan vasodilatori untuk 
semua ekstrak diselidiki dengan menggunakan in vitro ‘isolated aortic rings’ kajian. 
Antaranya, ekstrak air bagi P. ternata [PT (W)] dan C. reticulatae [CR (W)], ekstrak 50% 
etanol bagi G. elata [GE (50)] dan G. uralensis [GU (50) ], dan ekstrak 95% etanol  bagi 
A. macrocephala [AM (95)] dan P. cocos [PC (95)] merupakan ekstrak yang paling 
berkesan dalam kajian vasodilatori. Semua ekstrak ini akan digunakan untuk kajian 
kumpulan keserasian tindak balas ortogonal dengan formula L36 (6
6
). Nisbah optimum 
komponen herba dalam BBT ubahsuai (ABBT) adalah G. elata, A. macrocephala, G. 
uralensis, P. cocos, dan C. reticulatae dengan nisbah 1.14: 1: 2.71: 5.57: 7.14. Pelarut 
optimum untuk pengekstrakan ABBT adalah 50% etanol (ABBT-50). Ia kemudiannya 
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disahkan sebagai ekstrak yang paling berkesan dalam mempamerkan aktiviti vasodilatori 
berbanding dengan ekstrak lain dengan nilai EC50 dan Rmax sebanyak 0.05±0.005 mg/ml 
dan 127.50±3.60%. Kesan vasodilatori oleh ABBT-50 dikaitkan melalui mekanisme 
NO/sGC/cGMP dan PGI2, diikuti oleh saluran muscarinik dan saluran kalsium. Kesan 
antihipertensi ABBT-50 telah dikaji secara in vivo dengan pentadbiran oral rawatan pada 
tikus hipertensi spontan (SHR) selama 28 hari. Keputusan ini menunjukkan penurunan 
tekanan darah SHR yang ketara berbanding dengan kawalan negatif secara bergantung 
dos, sementara tanpa menyebabkan sebarang kesan negatif sekurang-kurangnya 
sehingga pentadbiran dos ABBT-50 yang tertinggi (1.488 g/kg) dalam model haiwan. 
Dengan pendekatan yang berasaskan bukti ini, BBT yang diubahsuai (ABBT) berjaya 
dibangunkan. ABBT bukan sahaja meningkatkan kesan terapeutik tetapi juga 
mengekalkan pendekatan teori ubatan TCM. 
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IN VIVO ANTIHYPERTENSIVE AND IN VITRO VASODILATORY STUDIES 
OF REFORMULATED BANXIA BAIZHU TIANMA TANG: 
PHARMACOLOGICAL OPTIMISATION USING ORTHOGONAL STIMULUS-
RESPONSE COMPATIBILITY MODEL 
 
ABSTRACT 
Banxia Tianma Baizhu Tang (BBT) is one of the most common Traditional 
Chinese Medicine (TCM) used for treating hypertension. However, differences in the 
herbs’ geographical location, time of harvest and processing when compared to ancient 
times has warranted modification in the formula. Although modification of BBT have 
been previously done (by addition of one or two other herbs in BBT), optimal 
reformulation of BBT for anti-hypertension has not been carried out. The authenticities 
of six raw herbs of BBT were verified by high performance thin layer chromatography 
(HPTLC) and Fourier transform infrared (FTIR) fingerprints identification methods. 
Three solvents (95%, 50% ethanol and water) were used for maceration process. The 
vasodilatory effects of all extracts were investigated by using the in vitro isolated aortic 
rings assays. Among the extracts, water extract of P. ternata [PT(W)] and C. reticulatae 
[CR(W)], 50% ethanol extract of G. elata [GE(50)] and G. uralensis [GU(50)], and 95% 
ethanol extract of A. macrocephala [AM(95)] and P. cocos [PC(95)] were found as the 
most potent extracts for exerting vasodilatory effects. These extracts were used for 
orthogonal stimulus-response compatibility group studies with L36 (6
6
) formula. The 
optimum ratios of herbal components in amended BBT(ABBT) are G. elata, A. 
macrocephala, G. uralensis, P. cocos, and C. reticulatae with the ratio of 
1.14:1:2.71:5.57:7.14. The optimum solvent for ABBT extraction was 50% ethanol 
(ABBT-50). It was further confirmed as the most potent extract in exhibiting 
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vasodilatory effects compared to other extracts at EC50 and Rmax values of 0.05±0.005 
mg/ml and 127.50± 3.60%, respectively. Vasodilatory effects of ABBT-50 were 
attributed via NO/sGC/cGMP cascade and PGI2, followed by muscarinic pathways and 
calcium channels. The antihypertensive effects of ABBT-50 were further investigated in 
vivo by 28 days oral administration on spontaneously hypertensive rats (SHRs). Results 
showed significant decrease of SHRs blood pressure compared to negative control in 
dose-dependent manner, whilst without causing any adverse effect at least until the high 
dose (1.488 g/kg) of ABBT-50 administration in animal models. With this evidence-
based approach, a new amended BBT (ABBT) was successfully developed. ABBT did 
not only enhance the therapeutic effect but also retained the traditional theoretical 






1.1 Hypertension in Malaysia 
 Cardiovascular diseases are the largest contributor of noncommunicable 
disease, with hypertension as the major contributor among many others. Hypertension is 
medically defined as the persistent elevation of systolic blood pressure (SBP) of 140 
mmHg (or greater) and/or diastolic blood pressure (DBP) of 90 mmHg (or greater). It 
can be further categorized into three stages, namely stage 1 (mild), stage 2 (moderate) 
and stage 3 (severe). Patients with SBP ranging between 120-139 mmHg or DBP of 80-
89 mmHg are categorized as pre-hypertension (WHO, 2012; Malaysia society of 
Hypertension, 2013; Leong et al., 2015; Naing et al, 2016). On top of that, there are 
three types of hypertension namely essential, primary, and idiopathic hypertension. 
These three types of hypertension are defined as high blood pressure (BP) where 
secondary causes such as renovascular disease, renal failure, pheochromocytoma, 
aldosteronism, or other causes of secondary hypertension or mendelian forms 
(monogenic) are not present (Carretero and Oparil, 2000). Essential hypertension 
accounts for 95% of all cases of hypertension. It is a heterogeneous disorder, with 
different patients having different causal factors that eventually leads to high BP. 
Essential hypertension is further separated into various syndromes because the causes of 
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high BP in most patients presently classified as having essential hypertension can be 
recognized. Long-term hypertension often bundles with other cardiovascular disease risk 
factor including elevated cholesterol level, diabetes, and obesity (Malaysia society of 
Hypertension, 2013; Leong et al., 2015; Risso-Gill et al., 2015). The relationship 
between BP and risk factor of cardiovascular disease is continuous, consistent and 
independent of others risk factor. The higher the BP, the greater the chances of getting 
stroke, heart failure, myocardial infarction and kidney disease. Untreated hypertension 
also leads to an increase in the mortality rate of both developed and developing country. 
In recent years, hypertension is considered as the number one silent killer in Malaysia 
(Malaysia society of Hypertension, 2013; Leong et al., 2015). 20% of people with 
hypertension are in the dark living with the condition without ever knowing they have it, 
they eventually develop fatal conditions (cardiovascular diseases, stroke) due to the 
persistent elevated blood pressure acting on the arteries (Risso-Gill et al., 2015; Naing et 
al., 2016). Hypertension is the common cause of mortality worldwide, encompassing 
developed nations like United States as well as developing nations like Malaysia (WHO, 
2012). Globally, it is estimated that at least one billion of the world population is 
affected by hypertension. In Malaysia during the year 2007, up to 30% of those aged 
over 18 had hypertension as reported by Malaysia Society of Hypertension. In 2011, the 
National Health and Morbidity Survey conducted in Malaysia, which includes 28,000 
subjects, found that 32.7% of participants at age 16 and over had hypertension (Malaysia 
society of Hypertension, 2013; Leong et al., 2015; Risso-Gill et al., 2015). It is 
unsurprising that the amount of people living with hypertension is rising rapidly in 
Malaysia every year due to unhealthy dietary habits and lifestyles. Another more 
concerning trend is that hypertension has continuously shown increasing prevalence in 
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younger populations annually. However, only 34.6% of people living with hypertension 
are aware of their status and mere 32.4% are taking any anti-hypertensive medications.  
Among those who are actively taking medication, only 26.8% had their BP under control 
(Risso-Gill et al., 2015). This suggests that the situation may be a catastrophe in the near 
future and formal medication might not be adequate for hypertension treatment. This 
situation pushes people to seek for alternative medicines. Although western medicines 
are well studied and very effective in treating hypertension, the reception from the 
Malaysian local population is not very optimistic. This is because there are alternatives 
and complementary medicinal systems mainly in spiritual or faith healers such as 
traditional Malay healers (bomohs), the Ayurvedic practitioners, as well as ancient 
medicine scholars in practitioners of Traditional Chinese Medicine (TCM) available as 
options. The widespread use of alternative medicine for treatments of illnesses in 
Malaysia is passed down from generations of multi-diverse ethnicity environment that 
existed here (Risso-Gill et al., 2015). These practices are a vital part of the everyday 
lives of local people since the knowledge often times entangles with some elements of 
faith, a main driving force behind living principals of Malaysians. However, these 
traditional medicine practices generally have lacked the appropriate scientific data to 
support the therapeutic effects they claimed to possess. There is also widespread belief 
that long-term consumption of western medication would deteriorate internal organs 






1.2 Traditional Chinese Medicine Applied in Treatment of Hypertension  
1.2.1 History of Chinese medicine 
History of Asian medicine began in China over 5,000 years ago and it is still 
practiced in virtually everywhere in the world today. Commonly known as Traditional 
Chinese Medicine (TCM), the discipline gathers its experience from millennia worth of 
daily uses as well as through countless repetitions, experimentation, insights and wisdom 
of predecessors studying and practicing it. TCM is not a folk medicine, but rather a 
complete medical system, using the perceived laws of nature as rules for understanding 
disharmony and diseases (Liu, 2009; Xiong et al., 2015). TCM actually rely on empirical 
applications and experience distilled over thousands of years (Zhang et al., 2016). The 
oldest known book about TCM is The Yellow Emperor's Inner Classic. It was 
compiled before 200 B.C. It's a summary of medical ideas and techniques that were in 
use even longer before itself. Today, Chinese medicine has expanded far beyond the 
Inner Classic with countless variations and innovations appearing throughout the 
centuries. TCM plays an indispensable role in health care (diagnostics, prevention and 
treatment) especially for the Chinese folks as a complete medical knowledge system 
alongside orthodox medicine (Liu, 2009). Even with such rich history and records, it is 
still a progressing field which focuses on two basic fundamentals which are yin yang 
(the concept of two opposites), and wu xing (five elements, consist of Metal, Wood, 
Water, Fire, and Earth). Combining these two theories, it explains the changes as well as 
all natural phenomenon in this universe including human beings, making the approach of 
TCM a holistic one (Chen and Chen, 2001; Liu, 2009). Also, these root principles, such 
as yin yang, describes the natural laws, that our body must ultimately obey. These root 
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principles endow Chinese herbs with a unique set of insightful knowledge, making it in 
some ways, far more evolved than modern technological medicine.  
Moreover, TCM actually can be split into herbal medicine, acupuncture, 
cupping, Taichi and Qigong. Most of them have claimed to be effective in treatment of 
hypertension (Xiong et al., 2012). Among them, herbal formulation from Chinese 
materia medica (CMM) is the more familiar façade of TCM for local folks. Syndromes 
of the disease, also known as „pattern‟ or „zheng’, is the differentiation of symptoms and 
signs of an illness identified from the comprehensive analysis using the four diagnostic 
methods, namely inspection, auscultation and olfaction, inquiry, and palpation (Xiong et 
al., 2013; Yang et al., 2013;). From the diagnosis, the major disharmonious pathogenesis 
and syndromes will be abstracted, and a prescription that normally contains more than 
one herb will be prescribed to the patient based on this information. The entire process is 
known as the syndrome differentiation treatment (Xiong and Wang, 2012). 
Unfortunately, the syndrome differentiation treatment sometimes produces difficulties 
for the clinical and scientific research of TCM. Currently, a mode of disease-syndrome 
combination has been suggested and has been successfully applied by prestigious TCM 
physicians (Sun et al., 2010a; Xiong et al., 2013). This new mode has changed the 
treatment philosophy of TCM, becoming the cornerstone of treatment in TCM and also 
pushing TCM into modern clinical treatment.  Due to its unique philosophy and 
treatment pattern, TCM was recognized as one of the advance medical sciences until the 
late 17
th
 century. Until now, TCM (especially its herbal formulae) have been widely 
explored and their effectiveness is being proven by clinical trials today. Impressively, 
TCM has accumulated more than 100,000 formulae over past 2000 years. TCM having a 
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sturdy reserve of formulae that are validated sets it apart from any other traditional 
herbal therapies across the world as a legitimate candidate for real world applications. 
(Wang et al., 2014). Therefore, a series of Chinese herbs have been recommended by 
TCM practitioners to treat hypertension such as Panax notoginseng, Alisma orientale, 
and Gastrodia elata Bl., due to their positive results and effectiveness in controlling 
blood pressure (Li, 2014). According to TCM syndromic theory, hypertension can be 
classified into three different types, such as fire, fluid retention, and deficiency 
syndromes, which can be treated with Tianma Gouteng Yin, Zhen Wu Tang and Banxia 
Baizhu Tianma Tang, respectively (Xiong et al., 2012; 2013; 2015). Western medicine 
emphasizes on specific mechanism of action while Chinese traditional medicine is 
focused on more holistic approach of merging these two systems (i.e. yin yang and wu 
xing) in treating hypertension so a superior effect may be observed (Xiong et al., 2013). 
1.2.2 Overview of Banxia Baizhu Tianma Tang  
Currently, systematic data retrieving researches have been carried out 
clinically to analyze the pattern in TCM and medicinal formulae used in anti-
hypertensive treatments for the past 20 years. Banxia Baizhu Tianma Tang (BBT) is one 
of the highly prescribed TCM formulae in hypertensive treatment (Li, 2014). Based on 
the Chinese Medica Formula textbook (Fang Ji Xue) (10.1.5 version), Banxia Baizhu 
Tianma Tang (a decoction) consists of six herbs, namely Pinellia ternate (Thunb.), 
Gastrodia elata Bl., Glycyrrhiza uralensis Fisch., Atractylodes macrocephala Koidz, 
Poria cocos (Schw.) Wolf, and Citri reticulatae Blanco (Deng, 2003; Sun, 2008; Li, 
2014). It is a classical TCM formula mentioned in Medical Revelations in Qing dynasty 
and widely used to treat hypertension related symptoms in clinical practice in China.  
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In TCM theory, usually more than one herb will be combined to form a 
formula and prescribed to the patient for treatment. These prescribed formulae are 
classical formulae from ancient TCM references.  According to TCM formulae theory, a 
formula is normally formed by four types of medicinal materials namely chief, deputy, 
assistant, and envoy medicinal. The chief medicine refers to the main medicine that 
affects major aspects of the disease. The deputy medicine coordinates with the chief 
medicine. The assistant medicine is used to strengthen the effect and/or relief the 
adverse effects of the chief and deputy medicines, while the envoy medicinal is used 
mainly to harmonize all the medicines in a formula (Yang et al., 2013). BBT is one of 
the better examples to demonstrate the combination theory in practice. The chief 
medicine in BBT is Pinellia ternate (Thunb.) and Gastrodia elata Bl.; the deputy 
medicine in BBT is Poria cocos (Schw.) Wolf and Atractylodes macrocephala Koidz; 
the assistant and envoy medicines in BBT are Citrus reticulata Blanco and Glycyrrhiza 
uralensis Fisch respectively (Deng, 2003). The roles and the medical uses of each herb 
are mentioned in Table 1.1. 
BBT is traditionally used to treat headache, dizziness, nausea and vomiting 
symptoms (mimic of the symptoms of hypertension in modern medicine) which is 
caused by fluid retention and liver yang hyperactivity syndromes (Sun et al, 2010a; 
Xiong et al, 2012). Modern researchers also proved that BBT has the potential of 
lowering BP administered through in vitro and in vivo. They also tend to combine this 
prescription with western anti-hypertensive drug for the treatment of hypertension. 




Table 1.1: The medical uses of each herb from BBT. 





Banxia Dries dampness, dissolves phlegm, redirects 
abnormally rising stomach Qi, relieves nausea and 
vomiting, dissipates nodules and disperses 
stagnation, treats sores, skin ulcerations and 
carbuncles 
Gastrodia elata Bl. Tianma Extinguishes wind and stops spasms and tremors, 
pacifies the liver and anchors Yang, relieves Bi 





Baizhu Tonifies Qi, strengthens spleen, dries dampness, and 
eliminates water accumulation 
Glycyrrhiza 
uralensis Fisch 
Gancao Tonifes spleen, benefits Qi, moistens the lung, stops 
cough, relieves pain, clears heat, eliminates toxins 
Poria cocos (Schw.) 
Wolf 
Fuling Promotes urination and resolves dampness, 
strengthens the spleen, calms the Shen (Spirit) 
Citrus reticulata 
Blanco 
Chenpi Regulates spleen and stomach Qi, dries dampness, 
dissolves phlegm, relieves cough 
 
Notes: Qi: The basic substance that constitute the universe. 
 
1.3 Pharmacology Study of Anti-Hypertensive Drug 
1.3.1 The arterial tone in cardiovascular system 
 The cardiovascular system is consists of the heart, which is an anatomical 
pump, with its intricate conduits (arteries, veins, and capillaries) that traverses the whole 
human body carrying blood. It is widely understood that the blood contains oxygen, 
nutrients, wastes, as well as immune and other functional cells that help provide for 
homoeostasis and facilitate basic functions of human cells and organs. Arteries and veins 
are usually composed of three layers; the innermost layer (tunica intima), central layer 
(tunica media) and outer layer (tunica adventitia). The cardiac cycle occurs between two 
heartbeats which consists of diastole (relaxation) and systole (contraction). The heart is 
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filled with blood during diastole, while the blood is pushed forward to the aorta during 
systole. These two heartbeats can be detected via monitoring blood pressure level in 
blood vessels. Regulation of BP in blood vessel depends on arterial tone which is 
determined by the interaction of the endothelium and the vascular smooth muscle cell 
(VSMC) (Yildiz et al., 2013; Loh et al., 2016).  
1.3.2 Endothelium-derived relaxing factors (EDRFs) 
 In cardiac vascular system, vascular endothelium acts as a major regulator of 
local vascular homeostasis by maintaining balance between vasorelaxation (vasodilation) 
and vasoconstriction. It synthesizes and releases a lot of vasoactive compounds. This 
entire range of vasoactive compounds are known as endothelium-derived relaxing factor 
(EDRF) and plays the fundamental role in the regulation and maintenance of 
homeostasis. The main EDRFs that relax arterial smooth muscle include nitric oxide 
(NO), prostacyclin (PGI2), and endothelium-derived hyperpolarizing factors (EDHF), 
which are associated with the activation of calcium-activated potassium channel (KCa) 
and inward rectifier potassium channel (Kir). Contrary to conventional intuition, the 
interaction between NO, PGI2 and EDHFs does not appear to be mutually exclusive but 
in actuality act synergistically in a complex manner in order to control a normal arterial 
tone (Ozkor and Quyyumi, 2011; Yildiz et al., 2013). 
 Previous research had reported that major vasorelaxant effect was mainly 
caused by NO, a substance synthesized by endothelial cell and diffuses into vascular 
smooth muscle cell. Once it enters VSMC, NO will stimulate the soluble guanylyl 
cyclase (sGC) while also be available for scavenging by superoxide anions (Moro et al., 
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1996). NO is produced by endothelial NO synthase (eNOS) from the breakdown of L-
arginine. The eNOS will hydroxylate L-arginine to N
ω
-hydroxy-L-arginine which is 
further oxidized to L-citrulline and NO (Jakala et al., 2009). Since NO plays a major role 
in controlling vascular tone, its production is tightly regulated by multiple mechanisms 
and signaling pathways. The eNOS activity can be stimulated by Ca
2+ 
calmodulin 
complex, phosphorylation of enzyme by protein kinase B (Akt), and protein kinase A 
(PKA) in endothelium. Synthesis of NO can be inhibited by antagonists such as N
ω
-
Nitro-L-arginin methyl ester (L-NAME).  
 In addition, the activation of cyclooxygenase (COX) can cause the formation 
of PGI2 from arachidonic acid (AA) (Berumen et al., 2012). Although PGI2 is mainly 
produced by prostacyclin synthase within the endothelium, VSMCs and fibroblast are 
also participants in the formation of PGI2 (Wong et al., 2010). The complete process for 
the formation of PGI2 is illustrated by Figure 1.1. COX is an enzyme and exists in two 
isoform which is COX-1 (mainly expressed in mammalian tissue) and COX-2 
(selectively expressed in some tissue in an inducible and transient manner). PGI2 is also 
produced in response to shear stress or substances that stimulate NO formation. Some 
researchers claimed that contribution of PGI2 towards vasodilation is less than that of 
NO. From the literature, the synthesis of PGI2 is inhibited by common anti-inflammatory 
drug such as indomethacin, ibuprofen, meclofenamic acid, and diclofenac. Indomethacin 
is a potent inhibitor of both COX-1 and COX-2 (Nichols and Nichols, 2008). 
 Apart from that, non-NO, non PGI2 mediated endothelium-dependent 
vasodilation has been partly attributed to endothelium-derived hyperpolarizing factors 
(EDHF). Endothelial hyperpolarization occurs due to several reasons that are site- and 
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species- specific, ultimately causing vascular smooth muscle hyperpolarization and 
relaxation (Ozkor and Quyyumi, 2011). Interestingly, the study on EDHF is scarce. 
Potential EDHF acts by increasing potassium conductance resulting in the subsequent 
propagation of depolarization of VSMC and eventual relaxation. One of the EDHFs 
starts with the release of acetylcholine which causes hyperpolarization of VSMC in the 
presence of intact-endothelium (Pires et al., 2013). This hyperpolarization is similar to 
certain potassium channel agonist and is unaffected by inhibitors of NO synthase or 
COX inside the endothelium. It contributes to the release of EDHFs and these EDHFs 
will activate the potassium channels in VSMC, allowing potassium efflux. Thus, 
resulting in membrane hyperpolarization and relaxation. Other substances are also 
reported to be EDHFs such as Epoxyeicosatrienoic acid (EETS) and hydrogen peroxide 
(Quyyumi and Ozkor, 2006; Wang, 2009). The EDHFs also work through the 
transmission of the endothelial cell hyperpolarization to the VSMC via gap junctions 
(myoendothelial). They couple endothelial cell to other endothelial cell and to VSMC, 
providing a low-resistance electrical pathway between the cell layers. Figure 1.1 shows 
the complete route of this EDHF‟s regulation in arterial tone. The experiment done by 
Ozkor and Quyyumi (2011) claimed that the contribution of EDHF increases as the 
vessel size decrease. Thus, study of EDHF in aorta is not recommended or feasible as 
the aorta is the biggest among all the blood vessels. 
1.3.3 Vascular smooth muscle cells (VSMCs) 
 The biological function of VSMCs in blood circulation is to cause contraction 
and relaxation in order to control the arterial tone, BP, and blood flow distribution. 
However, the relaxation or contraction effects are not solely controlled by VSMCs. 
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Some of the bioactive compounds such as NO from endothelium will diffuse into 
VSMCs and trigger the relaxation or prompt the contractile response in VSMCs 
(Balligand et al., 1993). The interaction between endothelium and VSMCs are closely 
related. Both act synergistically in a complex manner to maintain the normal arterial 
tone as shown in Figure 1.1. Also, the membrane depolarization and a number of 
chemical stimuli such as noradrenaline, angiotensin II, endothelin-1, vasopressin and 
thromboxane A2 by binding to their receptors can cause contraction in VSMCs as well 
(Chen et al., 2000; Goodman et al., 2001; Bockaert et al., 2006; Loh et al., 2016). 
1.3.3(a) Enzyme-linked NO/PGI2 pathway 
 In vascular tone regulation, the soluble type of guanylyl cyclase (sGC) is 
strictly linked to NO that diffuses into the VSMC after its synthesis in the endothelium 
(Nichols and Nichols, 2008). It may be transported across endothelial and vascular 
smooth muscles membranes. Activation of sGC by NO in VSMC leads to the conversion 
of guanosine 5‟- triphosphate (GTP) to cyclic guanosine 3‟, 5‟ -monophosphate (cGMP). 
Accumulation of cGMP will activate the protein kinase G (PKG), and thus, resulting in 
vascular smooth muscle relaxation since the activated PKG will reduce the intracellular 
Ca
2+
 release from SR store (Fellner and Adrendshorst, 2002). In addition, another 
vascular tone regulation relies on the chemical activity of adenylate cyclase (AC). AC is 
triggered by the binding of PGI2 to IP receptor in VSMCs (Wong et al., 2010). It will 
lead to an elevation in intracellular cyclic adenosine monophosphate (cAMP) and sub-




1.3.3(b) Channel-linked receptors 
 The channel-linked receptors are also known as ligand-gated channels and 
they are predominantly found in VSMCs (Nelson & Qualye, 1995; Littleton and 
Ganetzky, 2000). The channels respond by binding with chemical messengers and react 
by allowing the ions, such as calcium, potassium, sodium, chloride or magnesium to 
enter or leave the cell. The reaction of these receptors is regulated by the membrane 
potential, which is the difference of voltage between the inside and outside a cell. The 
membrane potential of every VSMCs is regulated by potassium channels, an important 
regulator of arterial tone (Jakala et al., 2009). There are four types of potassium channel 
in the blood vessel which are: calcium-dependent potassium channels (KCa), ATP-
sensitive potassium channels (KATP), voltage-dependent potassium channels (KV), and 
inwardly rectified potassium channels (Kir) (Nelson & Quayle, 1995). KCa channels 
consist of small-conductance (SKCa), intermediate-conductance (IKCa), and big-
conductance calcium-activated potassium channels (BKCa). The SKCa and IKCa channels 
are found to be more abundantly expressed in the endothelium, but expressed poorly in 
the VSMCs (Ding et al., 2002). Nelson & Qualye (1995) has claimed that SKCa and IKCa 
channels are able to contribute to EDHF and propagate to the adjacent VSMCs. 
Meanwhile, the BKCa channels are expressed only in VSMCs. The function of BKCa is to 
regulate membrane potential in small myogenic vessel; KV can limit the membrane 
depolarization and maintain the resting vascular tone; KATP helps to maintain the resting 
potential and local blood flow. The opening of these channels (BKCa, KV, KATP) in the 
cell membrane of VSMCs will cause the potassium ion (K
+
) efflux, which causes 





 channels, decreasing Ca
2+
 entry and leads to vasodilation. Unlike the other 
potassium channel, Kir channels only conduct K
+
 into the cell rather than out of the cell 
over a wide range of membrane potential (Jakala et al., 2009). The function of Kir is to 
induce the inward movement of potassium current and fasten the membrane potential to 
the resting stage (McFadzean and Gibson, 2002). The entire processes of potassium 
channels present in VSMCs are illustrated in Figure 1.1. 
 On the other hand, the VSMCs contraction can be initiated by mechanical, 
electrical, or chemical stimuli. The primary regulator of VSMCs contraction is the 
calcium ions (Ca
2+
) signal. The contractile stimuli trigger an elevation of the cytosolic 
Ca
2+
 concentration by activating either the release of Ca
2+ 
from intracellular stores 
(sarcoplasmic reticulum) or the Ca
2+
 influx from the extracellular space via L-type 
voltage-operate calcium channel (VOCC). VOCC appears to be dominant in most 
VSMCs (Aiello et al., 1995; Yildiz et al., 2013). VOCC opens during membrane 
depolarization, which leads to vasoconstriction, whereas hyperpolarization will cause 





 and calmodulin will activate MLCK. It will phosphorylate myosin 
regulatory light chain (MLC). Thus, phosphorylated MLC will then interact with actin to 
induce contraction (Nichols and Nichols, 2008). 
1.3.4 G protein-coupled receptors (GPCRs) 
 GPCR is a single polypeptide and it is located on intracellular surface of cell 
membranes. It will respond to ligands through the activation of the G-protein located on 
both endothelium and VSMC. Generally, G-protein (α, β, and γ-type) is activated when 
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bound to GTP while remain at resting state when bound to guanosine diphosphate 
(GDP). Once G-protein is activated by binding with GTP, it will cleave into Gα and Gβγ 
dimers. The α-type G-protein can be further classified into Gi, Gq, and Gs. Most of them 
tend to produce a direct effect in the increase of concentration of intracellular calcium by 
passing through PLC-dependent pathway (Harvey, 2012; Loh et al., 2016). One of the 
examples of Gq-coupled receptor in blood vessel is muscarinic receptor. There are five 
subgroups of muscarinic receptor (M1, M2, M3, M4, M5) but only M3 receptors are 
present in blood vessel, and predominantly in endothelial cell. In endothelial cell, 
activation of M3 will trigger the release of calcium from intracellular stores by 
stimulating PLC-dependent production of IP3 (Lowry and Huang, 2002). Hence, this 
process indirectly leads to the release of NO, PGI2 and EDRFs which diffuses into 
VSMCs and cause them to relax. In contrast, activation of M3 receptors will cause 
VSMCs contraction in the absence of endothelium. The M3 receptors in VSMCs involve 
the same PLC-dependent signaling mechanism that M3 receptors activate in endothelial 
cells. However, the increase of intracellular calcium will cause vasoconstriction in 
VSMCs by regulating calmodulin-dependent activation of the myosin light chain kinase 
(MLCK). On the other hand, the β2-adrenergic and IP receptor is coupled with Gs. Once 
stimulated, the activity of adenylyl cyclase (AC) will be triggered in VSMCs. It will 
increase the formation of cyclic adenosine monophosphate (cAMP), and cAMP will 
inhibit the MLCK that is responsible for smooth muscle contraction (Nichols and 
Nichols, 2008). Once MLCK activity is inhibited, there will be less contraction force, 
hence promoting vasodilation. The receptors coupled with Gs are less dominant in 






Figure 1.1: Overall signaling mechanism pathways take place in vascular endothelium 




1.4 Use of Animals for Hypertension Research 
 Animals have been used by plenty of researchers for centuries to study their 
own biology. Experiment animal models of hypertension have become a valuable tool 
for providing information on etiology, pathophysiology, and complication of diseases by 
studying the mechanism of actions of various drugs and compounds used in treatments 
(Evans, 2009b; Leong et al., 2015). Preclinical toxicity testing and mechanism of action 
(pharmacology effect) of newly developed drug may be investigated on animals before 
applied in human testing (Olson et al., 2000). This is vital as prior to testing on human, 
the effectiveness of a drug as potential treatment needs to be carried out on animals first. 
This step is crucial to ensure the dosage that will be employed in clinical trials do not 
cause fatality in the subsequent studies. Hence, animal models for hypertension are one 
of the most important tools in developing new pharmacological therapies. An ideal 
animal model for any disease should have several criteria including the feasibility and 
size of the animals, the reproducibility of the model, the ability to predict the potential 
antihypertensive properties of a drug, the similarity to human disease and economical, 
technical, and animal welfare consideration. (Dogrell and Brown, 1998; Evans, 2009a).  
  Among the animal species, rat is the preferred animal model. The use of rats 
as animal models is rational from economic viewpoint and many techniques have been 
developed and established to accurately measure their biological parameters (Dogrell 
and Brown, 1998; Leong et al., 2015). Along with rats, occasionally mice, monkeys, 
dogs, rabbits, guinea pigs and pigs are also used as a model for experimental 
hypertension. However, these species have not been studies extensively for both 
practical and financial reasons (Leong et al., 2015). For the in-vitro assay, a Sprague-
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Dawley (SD) rat is the ideal candidate animal model to investigate the pharmacology 
effect. Blood vessel such as aorta can be obtained easily from SD rats for detailed 
experimental and biological parameters examination related to hypertension (Loh et al., 
2016). Also, SD rat is easier to handle and manage, as compounding effects of their 
dietary and environmental factors can be controlled. Moreover, spontaneously 
hypertensive rats (SHRs) are also frequently used in hypertension study. The SHRs 
strain was obtained during the 1960s by Okamoto and colleagues, who started breeding 
Wistar-Kyoto (WKY) rats with high blood pressure. This species of rat possesses the 
genetic strain of hypertension and can be used in any hypertension study without the 
involvement of physiological, pharmacological or surgical intervention (Leong et al., 
2015). SHRs have become the obvious choice for in vivo screening of antihypertensive 
drugs and is recognized as the cornerstone of medical research in experimental 
hypertension (Trippodo & Frohlich, 1981; Dogrell and Brown, 1998). Besides that, BP 
of SHRs are measured by conventional heating (non-invasive) tail-cuff method. 
Although the invasive method such as carotid arterial cannulation is still used in 
hypertension investigation, it may cause severe injury to the animals and further 
complicates the experiment. Cannulation is also hardly used for BP measurement in 
experiments where long term treatment is observed, studied or investigated. Thus, non-
invasive tail-cuff method is strongly endorsed by most researchers to measure BP in 
long term hypertension studies (Krege et al., 1995; Leong et al., 2015). 
1.5 Problem statement and the research objective 
 There are several systematic reviews published throughout the years regarding 
the effect of TCM on hypertension, suggesting that Chinese herbal medicines are 
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effective and safer for treatment of hypertension when compared to conventional 
treatments (e.g., diuretics, beta-blockers, calcium-channel blockers, and ACE inhibitors), 
but the quality of evidence for these claims are mostly unclear (Xiong et al 2012; 2013). 
In order to investigate the efficacy and safety of TCM for treating hypertension, it is a 
must to further study the pharmacology behind it through rigorous and carefully planned 
sets of experiments. 
 Modification of the BBT (by addition of one or two others herb) have 
previously been studied by others (Xiong et al., 2012). However, the much essential 
reformulation of BBT has not yet been carried out. For this matter, it is worthy to note 
that the ratio of each herbal component in BBT has not been optimized for anti-
hypertension. Moreover, due to cultivation and environmental factors, the herbal 
component in BBT today might not be similar with BBT that was first developed at 
ancient times, and could exhibit some variation in its content and therapeutic effects. 
With evidence-based approach, a new amended BBT has been developed successfully 
using orthogonal stimulus-response compatibility model with L36 (6
6
) formulation. This 
amended BBT (ABBT) has not only enhanced the therapeutic effect but also retained the 
traditional theoretical approach of TCM. 
Thus, the aim of this study is:  
1. To decompose and reformulate the Banxia Baizhu Tianma Tang (BBT) in order 
to optimize its ratio for vasodilatory effect. 
2. To study the mechanism of action of vasodilation for the each potential herb 
from amended BBT via in-vitro isolated aortic ring assay.  
3. To evaluate the anti-hypertensive and toxicity effects of amended BBT via in-





HERBAL IDENTIFICATION AND VERIFICATION 
2.1 Introduction 
 Common clinical use of TCM combines two or more herbs usually found in 
Chinese materia medica (CMM) based on formulae derived from historical references 
and empirical evidence practitioners. This is a point of strong distinction or contrast 
from the usual “single chemical entity” approach that has formed the basis of modern 
pharmacology and drug development, while CMM reviews multi-compound, multi-
ingredient, the method of preparation with discrete prescription ratio to probe the 
activity of herbal drugs. With that being said, it is obviously necessary to revamp and 
invent a quality assessment system that can adequately describe the complex nature of 
CMM (Xie et al., 2006). Therefore, advance analytical techniques that are able to 
distinguish or interpret signals from multiple compounds found in these herbs, as well as 
their respective ratios or quantity will prove to be a better choice for the authentication 
and quality assessment of CMM. This leaves chromatographic fingerprint analysis that 
are able to isolate and identify mixtures of compounds in herbs and prescription mixes a 
rational approach for CMM‟s quality assessment.  
 HPTLC (High Performance Thin Layer Chromatography) is a product of 
analytical breakthrough having its core principal from its predecessor, thin layer 
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chromatography (TLC), a previously common method of choice for herbal analysis 
before the age of instrumental chromatography (Liang et al., 2004). Despite the outdated 
and error-prone as well as time consuming process, TLC is still frequently used for 
analysis of CMM and still is the front line fingerprinting technique recognised by 
Chinese Medicine Division of the Department of Health (2005) and Pharmacopoeia of 
the People‟s Republic of China (2010). However, more adoption of HPTLC is around 
the corner for reputable pharmacopoeias of the world due to the immense advantage that 
HPTLC brings over TLC. Development of HPTLC by CAMAG instruments 
(Switzerland) has eliminated most of the possible human error mostly associated with 
conventional TLC by automatising every step from sample spraying onto stationary 
phase, vapour saturation of gas chamber, suspension of plate in mobile phase with 
computer controlled precision, all the way to solvent dispensing, multiple UV 
wavelengths capturing, and plate development with wide choice range of reagents (Xie 
et al., 2006). The whole process is assisted with laser and sensors that calibrates and 
control all the measurements that are desired such as solvent front and base lines, sample 
volume sprayed, and mobile phase volume. Besides that, with the help of digitized 
technique for image analysis and high resolution image capturing, the evaluation of 
similarity between different samples is also possible. The CAMAG visualizer and 
scanner also made it possible to get useful qualitative and quantitative information from 
the developed TLC plate. All these advantages gave HPTLC its name, High-
Performance, with a promise of reduced time consumption, ease of use, robust and 
repeatable results without human errors, and richer analytical information (Wagner et al., 
2011; Geissler et al., 2017). 
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 For authentication purposes, the FTIR macrofingerprint characterization 
method was frequently being used to identify the herbs to prevent the use of any 
counterfeit herbs in the experiments. The conventional FTIR spectrum is a mean of 
spectral resolution enhancement to progressively enlarge the differences between the 
spectra of the samples in order to achieve identification distinction (Sun et al., 2003; 
2010b; 2011). The conventional FTIR spectroscopy is the basis of identification of the 
sample, constituting the “primary identification”. In brief, the entire pattern of 
compounds can then be evaluated to determine not only the absence or presence of 
desired markers but the complete pattern of each individual herb. Therefore, raw herbs 
used in BBT could be elucidated with chromatographic fingerprint analysis.   
 In this study, FTIR and HPTLC were employed for the herbal identification 
and verification. These two methods are used to construct specific patterns of 
recognition for the herbs fingerprint. The aim of this study was to identify the herbal 
used in the experiment by using HPTLC and FTIR method. We believed that HPTLC 
coupled with FTIR can offer a better fingerprint profile of the herbs used in the 
experiment. Thus, this way could be a useful addition to other analytical methods in the 
investigation of fake, adulterated and poor quality products. 
2.2 Methodology  
2.2.1 Sample collection and preparation  
 The Pinellia ternata (Thunb.) Breit, Pinellia ternata Praeparatum (processed  
Pinellia ternata, pretreated with ginger juice to reduce toxicity), Gastrodia elata Bl., 
Atractylodes macrocephala Koidz, Glycyrrhiza uralensis Fisch., Poria cocos (Schw.) 
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Wolf, and Citri reticulatae Blanco (the composition herbs of Banxia Baizhu Tianma 
Tang (BBT)) were purchased from Xiang Wang Sdn. Bhd., Malaysia. The standard 
reference of each raw herb were purchased from National Institutes for Food and Drug 
Control, Beijing, China. Hesperidin, gastrodin, atractylenolide I, liquiritin, glycyrrhizic 
acid, ursolic acid and linoleic acid were purchased from Chengdu Biopurify 
Phytochemicals Ltd. (China). Potassium bromide (KBr), 95% ethanol and the TLC plate 
(20 x 10 cm) were purchased from Merck (Germany). The entirety of solvent used for 
HPTLC was purchased from QReC (New Zealand). 
2.2.2 Macrostructure study of components of BBT 
 All the raw herb samples‟ macrostructures were examined before grinding and 
bioassay in order to confirm the authenticity of herbal. Macroscopic authentication was 
carried out using the naked eye. The raw herbs were identified according to the TCM 
identification guides (Chen and Chen, 2001; Pharmacopoeia of the People's Republic of 
China, 2010; Jan et al., 2017). The morphology of each herb was carefully observed and 
compared to the reference atlas. Each herbal were then ground into powder form by 
using an herbal grinder (Yongli YF3-1, Zhejiang, China).  
2.2.3 HPTLC identification 
 All the raw herbs were ground into powder form (200 mesh). The raw herbs 
and standard reference herbs were prepared at 100 mg/ml in methanol. The herb mixture 
was sonicated for 10 minutes at room temperature before centrifuged for 5 minutes at 
3000 rpm. The supernatant solution was then filtered with 0.45 µm PTFE syringe filter 
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before transferred into vials for HPTLC analysis. Each of the selected markers (standard 
compound) was prepared in accordance to Table 2.1. 
 HPTLC analysis was performed on 20 x 10 cm silica gel 60 F 254 HPTLC 
glass plates (Merck, Germany). 2 μl of samples were applied on the plate as bands of 8 
mm wide by using CAMAG Automatic TLC sampler (ATS 4) with spray-on technique. 
Bands were applied with a distance of 8 mm from the lower edge of the plate and 20 mm 
from both the left and right edges. The space between bands was 11 mm wide, and the 
number of tracks per-plate was 15 (Pharmacopoeia of the People's Republic of China, 
2010; Wagner et al., 2011). The samples were then developed with mobile phase as 
listed in Table 2.1 with development distance of 70 mm from the lower edge of the plate 
using CAMAG Automatic developing chamber (ADC2). The ADC2 was pre-
concentrated with 10 ml mobile phase for 10 minutes to achieve 37% relative humidity 
prior to the development of TLC. The image of the developed TLC plate was examined 
using TLC visualizer at 254, 366 nm, and white light illumination, and their images were 
captured for further analysis. Firstly, the spectrum of each marker band was scanned 
from 200-450 nm, the maximum absorbance unit (AU) for each marker will be selected 
for quantification process. The contents of samples in the selected wavelength were 
calculated from the calibration curves of each compound (Geissler et al., 2017). For 
derivatization, the plate was sprayed with derivatization reagent (The derivatization 
reagent for each herb as listed in Table 2.1) and was subsequently heated by using plate 
heater (Heidolph, Germany) for 5 minutes at 105°C. The derivatized plate was examined 
in TLC visualizer under white light, 254 and 366 nm illumination and images were 
captured for comparison purposes. 
